All News #Library
Generics
Genentech’s Gazyva Shows Superiority in Active Lupus Nephritis
07 Feb 2025 //
BUSINESSWIRE
Biogen Sued Over Alleged PBM Kickbacks For Tecfidera
21 Aug 2024 //
FIERCE PHARMA
Russia registers domestic generic of Spinraza
14 May 2024 //
THE PHARMA LETTER
Biogen notches another Tecfidera patent win in Europe
20 Dec 2023 //
FIERCE PHARMA
Biogen finally scores win in its fight to prevent copycats of MS drug in the EU
04 May 2023 //
ENDPTS
Biogen Int`l v. Banner Life Sciences LLC (Fed. Cir. 2020)
30 Apr 2020 //
PATENTDOCS
Tecfidera (Dimethyl Fumarate) : Biogen vs. Accord Healthcare
14 Feb 2019 //
PATENT LITIGATION
Cerdelga (eliglustat) : Genzyme vs. Cipla Ltd.
24 Nov 2018 //
PATENT LITIGATION
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Sun Pharma
01 Nov 2018 //
PATENT LITIGATION
Forward Pharma loses appeal in Tecfidera patent dispute with Biogen
25 Oct 2018 //
REUTERS
Tecfidera (dimethyl fumarate) : Biogen International v. Windlas Healthcare
31 Aug 2018 //
PATENT LITIGATION
Rituxan® (Rituximab): Genentech, Inc. et al v. Celltrion, Inc. et al
16 Jul 2018 //
PATENT LITIGATION
Gilenya patent decision gives MS market a reprieve
14 Jul 2018 //
BIOPHARMA DIVE
MS patent win boosts Novartis’ Gilenya, but helps Celgene, too
13 Jul 2018 //
FIERCE PHARMA
Tecfidera®(Dimethyl Fumarate):Biogen International Gmbh v. Zydus Pharma (USA)
25 Apr 2018 //
PATENT LITIGATION
Tecfidera®(Dimethyl Fumarate): Biogen International Gmbh v. Banner Life Sciences
18 Apr 2018 //
PATENT LITIGATION
Tecfidera®(Dimethyl Fumarate): Biogen International Gmbh V. MSN Laboratories
01 Mar 2018 //
PATENT LITIGATION
Tecfidera® (Dimethyl Fumarate): Biogen V. Caribe Holdings (Cayman)
19 Jan 2018 //
PATENT LITIGATION
Rituxan®(Rituximab): Genentech v. Celltrion
12 Jan 2018 //
PATENT LITIGATION
Tecfidera® (Dimethyl Fumarate): Biogen International Gmbh v. Zydus Pharma
30 Jun 2017 //
PATENT LITIGATION
Biogen wins Tecfidera U.S. patent dispute with Forward Pharma victory- generics
04 Apr 2017 //
FIERCE PHARMA
Generic Drug Helps Multiple Sclerosis Damage in Mid-Stage Trial
13 Apr 2016 //
BLOOMBERG
Biogen`s Tecfidera faces new challenge as scientists call for brain infection monitoring
07 Aug 2015 //
FIERCE PHARMA

Market Place
Sourcing Support